19.11.2014 • News

AkzoNobel US Subsidiary Said Defrauded of €53 million

A US subsidiary of AkzoNobel based in Chicago has been been defrauded of up to €53 million, the Dutch chemical producer said, without providing details.

The company said it had taken immediate action to stop the fraud when detected and that it might be able to reduce the financial impact. An independent legal counsel assisted by an independent audit firm has been assigned to investigate the matter, it added.

AkzoNobel said the fraud appeared to be an isolated incident not linked to its operational activities. The company did not indicate whether any of its own employees were involved.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.